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Antioxidant activityAbstract Salak (Salacca zalacca) is well-known as snake fruit and it is immensely studied for its
antioxidative and antidiabetic active metabolites throughout the southeast Asian countries. How-
ever, there are many remaining unidentified metabolites due to very low abundance and natural
variation, which need to be further explored. Nowadays mass spectrometry (MS/MS) facilitates
the tentative identification of unknown compounds in the crude herbal extracts. This study
described the metabolite profiling of hydroalcoholic extracts of S. zalacca analysed by LC-
QTOF-MS/MS. The 60% ethanolic extract exhibited the highest a-glucosidase inhibition and ferric
2 M.S.M. Saleh et al.reducing antioxidant power activities with IC50 of 15.94 mg/mL and 78.13 lg AAE/g, respectively.
Multivariate data analysis (MVDA) by an orthogonal partial least-squares (OPLS) algorithm was
conducted to correlate the a-glucosidase inhibition activity with the LC- QTOF-MS data. A total of
4 compounds were reported for first time in this fruit and identified based on the molecular mass
and fragment ions. LC-QTOF-MS analysis indicated the presence of carexane I, 5-phenoxytetra
zol-1-yl)-2,3,5,6-hexahydrofurofuran-3-ethylurea, 3-acetylphenoxy)-N-[(2)-1-amino-4-methyl-1-oxo
pentan-2-yl]-4,5-dihydroxycyclohexene-1-carboxamide and Ethyl 4-[5-methyl-2-oxo-10,20,50,60,70,70
a-hexahydro-1H-spiro[indole-3,30-pyrrolizine]-20-ylamido] benzoate. Molecular docking of those
compounds with the a–glucosidase enzyme was performed to confirm their antidiabetic potential.
These bioactive compounds could be suggested as a-glucosidase inhibitors and functional food
additives.
 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder that
may lead to other macro- and micro-vascular complications.
Type 2 DM is also known as non-insulin dependent diabetic
mellitus (NIDDM) that accounts for more than 90% of all
DM cases [1]. It is characterized by abnormal increase in blood
glucose level (hyperglycemia) as a result of either insulin resis-
tance or insulin deficiency or both (Patel and Macerollo, 2010).
The symptoms of type 2 DM are similar to those observed in
type 1 DM. There are many underlined factors responsible for
type 2 DM. These include changes in life style, such as lack of
body physical activity and high calorie intake, environmental
factors as westernization and epidemiology, and genetic factor
like family history (Tee and Yap, 2017). There are other dis-
eases associated with type 2 DM, which include obesity, dys-
lipidemia and hypertension. History of impaired glucose
tolerance (IGT), gestational diabetes and aging are also predis-
posing factors. If type 2 DM is poorly managed or ignored, it
may cause different long-term complications, such as
nephropathy (kidney failure), retinopathy (eye disease), neu-
ropathy (nerve damage), foot sores and ulcers (peripheral vas-
cular diseases).
a-Glucosidase (EC 3.2.1.20, a-D-glucoside glucohydrolase)
is an enzyme secreted from the epithelium of intestine and cat-
alyzes by the degradation of polysaccharides to monosaccha-
ride (Moritoh et al., 2009). The inhibition of a-glucosidase is
likely to interfere the digestion of carbohydrate and ultimately
decrease the risk of postprandial hyperglycemia in diabetic
patients. Currently, two types of drugs are used to inhibit
the enzymatic activity of the a-glucosidase in the intestine,
including the acarbose and the miglitol, which consequently
reduce the postprandial hyperglycemia. However, the pro-
longed usage of these medications is frequently associated with
undesirable side effects depending on dose, including abdomi-
nal pain, diarrhea, and flatulence. (Etxeberria et al., 2012).
Therefore, the search for effective and safe a-glucosidase inhi-
bitors from natural sources to develop a physiologically func-
tional food, or to design drugs for use against diabetes, is of
great interest. Several medicinal plants are used in different
parts of the world for the treatment of DM (Saleh et al.,
2020a). Numerous studies have shown the potency of the crude
extracts of different plants as well as specific bioactive com-
pounds in lowering blood glucose level (Su et al., 2013).Salacca zalacca (Gaertn.) Voss (Arecaceae) is globally
known as snake fruit and locally called salak in Malay lan-
guage (Saleh et al., 2020b). It is widely distributed in South
Asia and widely used as potential medicinal plant in recent
times due to its anticancer, antioxidant, antidiabetic, and
anti-inflammatory properties (Aralas et al., 2009; Saleh et al.,
2018a). Sterols, phenolics, flavonoids, alkaloids and tannins
are natural constituents of S. zalacca fruit (Leontowicz et al.,
2006; Zaini et al., 2013). According to our previous study,
the flesh of S. zalacca exhibited good a-glucosidase inhibition
activity (Saleh et al., 2018b). However, it was difficult to iden-
tify bioactive metabolites only by FT-IR-based metabolomics.
The LC-MS can be applied to compare the different ethanolic
extracts from this fruit due to its precision and high sensitivity.
The application of LC-MS for studying the bioactive com-
pounds of these extracts is limited and warrant further
research. Technically, this study was aimed to correlate the
a-glucosidase inhibitory activity of S. zalacca fruits ethanolic
extracts to their metabolites identified by MS, applying multi-
variate data analysis (MVDA) to identify its potential a- glu-
cosidase inhibitors. Apart from that, all the inhibitors
identified were subjected to molecular docking study using
Saccharomyces cerevisiae isomaltase crystal structure obtained
from the protein data bank. This in silico analysis can help to
visualise the binding mode and interaction between the inhibi-
tors and the proteins that cause the inhibitory activity.
2. Methods and chemicals
2.1. Chemicals
Methanol, sodium hydroxide and glycine were obtained from
Merck (Darmstadt, Germany). Ethanol, potassium dihydro-
gen phosphate (KH2PO4), sodium carbonate (Na2CO3) and
dimethyl sulfoxide (DMSO) were purchased from HmbG
Chemicals Inc (Hamburg, Germany). Hydrochloric acid,
formic acid and acetic acid were purchased from R & M
Marketing (Essex, UK). Quercetin, p-nitrophenyl-a-D-
glucopyronase (PNPG), ascorbic acid, 1,1-diphenyl-2
picrylhydrazyl (DPPH, 95%), 2,4,6-tris (2-pyridyl)-s-triazine
(TPTZ, 99%) and iron (III) chloride hexahydrate were
obtained from Sigma-Aldrich (St. Louis, Mo., USA). The
a-Glucosidase enzyme from Saccharomyces cerevisiae was
procured from Megazyme (Wicklow, Ireland).
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The fresh fruits of S. zalacca were collected from Bukit Sagu
plantation, Felda (Kuantan, Malaysia) and authenticated by
the botanist Dr. Shamsul Khamis and the voucher specimen
(PIIUM 0215) was deposited in the Kulliyyah of Pharmacy,
International Islamic University Malaysia. The fruits were
washed, peeled before cutting to small pieces. The flesh of
the fruits were dried using the freeze dryer for 6 days. The
dried fruits were ground using a laboratory blender to obtain
very fine powder and kept at  80 C. Ten grams of ground
fruits were placed in 500 mL conical flask followed by adding
300 mL of ethanol/water with various ratios (0:100, 20:80,
40:60, 60:40, 80:20 and 100:0; v/v). The mixtures were sub-
jected to a sonicator bath for 1 h at room temperature
(30 C). The mixtures were then filtered through a Whatman
filter paper (No. 1), concentrated using a rotary evaporator
under vacuum at 40 C and lyophilized in freeze drier (Saleh
et al., 2018a). The crude extracts were stored at  80 C for
future biological activities and LC- QTOF-MS analysis.
2.3. Determination of total phenolic content
The total phenolic content (TPC) of the S. zalacca fruit
extracts was determined according to the previously described
method (Ikram et al., 2009). Briefly, 50 lL of the extract solu-
tion was pipetted in a 96–well microplate, and then, it was
mixed 50 lL of freshly prepared Folin–Ciocalteu reagent
(10–fold dilution). The mixture was left to react at room tem-
perature for 5 min, and then, 50 lL of 7.5% (w/v) Na2CO3 was
added. After 45 min of incubation at room temperature, the
absorbance was measured at 725 nm using UV–VIS spec-
trophotometer (Tecan, Männedorf, Switzerland). The stan-
dard curve was prepared using 50, 100, 150, 200, and
250 lg/L solutions of gallic acid in methanol. The results were
expressed as lg of gallic acid equivalents per milligram dry
weight (mg GAE/mg dry weight).
2.4. Determination of total flavonoids content
Total flavonoids content (TFC) of S. zalacca extracts was esti-
mated according to the published procedure (Lou et al., 2014).
Briefly, 0.1 mL of extract’s solution was added to 0.1 mL 2%
(w/v) of aluminium chloride. Then, the reaction mixture was
incubated for 1 h at room temperature, and absorbance was
determined at 415 nm using UV–VIS spectrophotometer. A
standard curve was constructed on the absorbance of quercetin
between 5 and 200 mg/mL and the total flavonoid content was
presented as mg of quercetin equivalents (QE) per 100 g dry
extract.
2.5. Biological activity measurement
2.5.1. a-glucosidase inhibitory activity
The a-glucosidase inhibitory activity of the fruit’s extracts was
estimated according to the methods described by Collins et al.
(1997) with slight modifications. Briefly, A 100 mL of 30 mM
phosphate buffer with pH 6.5 was added to each well and
10 mL of different concentrations (i.e., 320, 160, 80, 40, 20,
10, and 5 mg/mL) of S. zalacca fruits extracts were added toeach well. A stock solution of the substrate p-nitrophenyl-a-
D-galactopyranoside (PNPG) was initially prepared with
6 mg in 20 mL of 50 mM phosphate buffer pH 6.5. Quercetin
(dissolved in DMSO) was used as a positive control. All the
extracts were dissolved in DMSO. Afterwards, 15 mL of a-
glucosidase enzyme solution (0.02 U/well) was added and
allowed to incubate for 5 min at room temperature. After that,
75 mL of substrate (PNPG) was added to each well, and left for
15 min. By adding 50 mL of (2 M) glycine of pH 10, the reac-
tion was stopped. The absorbance was measured using a spec-
trophotometer at 405 nm. The a-glucosidase inhibition was
calculated based on the following equation:
a-Glucosidase inhibitory activity (%)= [(AcontrolAsample)/
Acontrol]  100%
Where Acontrol is the absorbance control and Asample is the
absorbance of sample.
IC50 is the concentration of extract required to inhibit 50%
of the a-glucosidase inhibitory activity.
2.5.2. DPPH free radical scavenging activity
The free radical scavenging activity was determined as previ-
ously reported (Karthivashan et al., 2013) with slight modifica-
tion. Briefly, 3.94 mg of DPPH was dissolved in 50 mL
methanol. About 80 lL of the methanolic solutions of DPPH
(0.2 M) was added to 20 lL extract in a 96–well microplate. An
equal amount of alcohol was added to the control. Then, it was
left in the dark at room temperature, and the absorbance was
measured at 540 nm after 10 min. Ascorbic acid was used as a
positive control. A control reaction was carried out without
the test sample. Absorbance values were corrected for radical
decay using blank solution. The percentage inhibition of the
DPPH radical by the samples was calculated according to
the following formula:
% inhibition ¼ fðAcontrol  AsampleÞ=Acontrolg  100%
Where Acontrol is the absorbance control and Asample is the
absorbance of sample.
2.5.3. Ferric reducing antioxidant power
The ferric reducing antioxidant power (FRAP) assay was
determined according to the previously reported method
(Szydłowska-Czerniak et al., 2011). A FRAP stock solution
was initially prepared as 2.5 mL of a 10 mM TPTZ solution
in 40 mM HCl, 2.5 mL of 20 mM FeCl3, and 25 mL of
0.1 M acetate buffer pH 3.6. The mixture was incubated in
the oven for 10 min at 37 C. About 20 lL of each different
extract of S. zalacca was added to 40 lL of FRAP solution,
followed by 140 lL of distilled water in a 96–well microplate
produces a blue–coloured solution. Then, it was left at room
temperature for 20 min in the dark. The absorbance was mea-
sured at 593 nm with a spectrophotometer and the standard
curve was constructed. The results were corrected for dilution
and expressed as lg of ascorbic acid/mg (mg AA/mg).
2.6. LC-QTOF-MS analysis
LC-QTOF-MS analysis was carried out according to Lawal
et al. (2016) with some modifications. Briefly, 10 mg of each
extracts was dissolved into 1 mL of 80% methanol then filtered
through 0.45 mL microsyringe filter. The samples were injected
on a Phenomenax Kinetex C18 core–shell technology 100 Å
4 M.S.M. Saleh et al.(250  4.6 mm, 5m). The mobile phase consisted of 0.1% for-
mic acid in water (solvent A) and methanol (solvent B). The
composition gradient was: 0 min, 5% solvent B, 0–10 min,
100% solvent B, 10–20 min, 100% solvent B; 20–25 min 5%
solvent B and 25–30 min 5% solvent B, with flow rate of
0.7 mL/min. The Q-ToF was operated in electrospray ioniza-
tion (ESI) negative mode. Voltages of the capillary and sam-
pling cone were set at 3 kV and 30 V, respectively. The
desolvation flow was set to 700 L/h at 300 C and the source
temperature was set to 110 C. The Q-ToF MS data were col-
lected in the range of m/z 100 to 17,000 with a scan time of
0.2 s and the interscan delay time of 0.02 s. MS/MS data
collection-range: m/z 100 to 1700 with the scan rate of 1 spec-
tra/ scan with collision energy ramp of 30 to 35 eV.
MS data were acquired and analyzed with ACD/Spec Man-
ager v.12.00 (Advanced Chemistry Development, Inc., ACD/
Labs Toronto, Canada). The raw (*.xms) files were subse-
quently converted to netCDF (*.cdf) formats using ACD/Spec
Manager v.12.00 (Advanced Chemistry Development, Inc.,
ACD/Labs Toronto, Canada). After conversion, the files were
subjected to pre-processing, peak extraction, retention time
correction, and alignment with XCMS (an acronym for vari-
ous forms, X, of chromatography mass spectrometry). The
XCMS package in R version 2.15.1 language (www.biocon-
ductor.org) were performed by simple commands using
XCMS’s default settings (http://masspec.scripps.edu/
xcms/documentation.php). The resulting peak list was
exported as a *. txtfile to Microsoft Excel (Microsoft, Red-
mond, WA). A list of the peaks detected was generated using
the average area, corrected retention time, and m/z data as
the identifier for the various peaks.
2.7. Molecular docking
Molecular docking is an important tool for exploring the inter-
actions between an inhibitor molecule and the protein target.
The crystal structure of a-glucosidase is not available yet, so,
we used homology model as described by Murugesu et al.
(2020). In brief, a 3D homology model of Saccharomyces cere-
visiae a-glucosidase was constructed based on the complex
crystal structure of a-d-glucose bound oligo-1,6-glucosidase
with PDB ID: 3A4A which shares 85% similar and 72% iden-
tical sequence with a-glucosidase. The chemical structures of
five pure compounds were obtained from the PubChem com-
pound database (https://pubchem.ncbi.nlm.nih.gov). All the
water molecules were removed from the protein structure using
the AutoDockTools (The Scripps Research Institute, La Jolla,
CA, USA) of the version 1.5.6. Prior to the molecular dock-
ings, the homology model of the enzyme was developed
according to the assay condition with pH of 6.5 using
PDB2PQR Server, version 2.0.0 (National Biomedical Com-
putation Resource, San Diego, CA, USA). After the docking
process, the grid box resolution was centred at 21.272 X  0.
751 X 18.633, respectively along the x, y, and z axes, respec-
tively, at a grid dimension of 126 Å  126 Å  126 to define
the binding site. For the ligands, Gasteiger charges were
added, while the rotatable bonds in the ligand were assigned
with AutoDockTools and all torsions were allowed, to rotate.
The docking jobs were performed with AutoDock using the
Lamarkian genetic algorithm. A population size of 150 and
energy evaluations of 2,500,000 (medium) were set to generate50 ligand docked conformations. Biovia Discovery Studio
(Biovia, San Diego, CA, USA) software was used to generate
the 2D of interactions between the protein residues and the
compounds. 3D superimposed diagram of the complex was
rendered using PyMOLTM 1.7.4.5 (Schrödinger, LLC, New
York, NY, USA).
2.8. Statistical analysis
The data were analyzed using the Minitab V17 (Minitab Inc.,
State College, PA). The data were subjected to analysis of
ANOVA by Tukey’s test comparison. All the experiments were
performed in 6 replicates and the results were presented as
mean ± SD. The difference was considered statistically signif-
icant when the P value was below 0.05.
3. Results
3.1. Total phenolic content and total flavonoid content
The results obtained from the TPC assay is shown in Table 1.
TPC ranged from 3.08 to 14.94 mg GAE/mg. The TPC of
100% ethanol (E100) extract was 14.65 ± 0.56 mg GAE/mg
and E60 extract had the highest TPC of 14.94 ± 0.96 mg
GAE/mg, whereas E0 contained the lowest TPC of 3.08 ± 0.
22 mg GAE/mg. The total flavonoid contents (TFC) of differ-
ent extracts are presented in Table 1. The E80 extract showed
the highest value with 12.37 ± 0.50 mg QU/100 g TFC,
whereas E0 contained the lowest TFC of 4.96 ± 0.24 mg
QU/100 g as compared to the other extracts.
3.2. Antioxidant activity of S. Zalacca
The free radical scavenging activity was changed in a
concentration-dependent manner as shown in Table 1. From
all tested concentrations, the E80 extract displayed the stron-
gest radical scavenging activity with 61.32% (P < 0.05) as
compared to standard (ascorbic acid i.e., 99.04%). This was
followed by the E100, E60, E40, and the least scavenging activ-
ity was obtained in E20 and E0 extracts of S. zalacca’s fruit
i.e., 55.95, 54.14, 40.59, 39.22, and 36.18%, respectively. In fer-
ric reducing antioxidant power assay, the reduction is done by
a single electron from Fe3+ in the solution to Fe2+ (Mohamed
et al., 2014). Results obtained from ferric reducing antioxidant
power assay were expressed quantitatively in terms of lg
ascorbic acid equivalent (AAE) per lg of ascorbic acid/g.
For this study, ascorbic acid was used as standard. As shown
in Table 1, it is obvious that E80 extract of the fruit of S.
zalacca showed the highest antioxidant activity with 78.39
AAE lg. The activities of the other extracts were observed in
the decreasing order as E60 ˃ E100 ˃ E40 ˃ E20 ˃ E0 with
the values of 78.13, 75.55, 72.54, 63.43 and 55.46 AAE lg of
ascorbic acid/mg, respectively.
3.3. a-Glucosidase inhibitory activity
Table 1 displays the IC50 values of S. zalacca fruits extracts
obtained from the a- glucosidase inhibitory assay. The results
showed that E60 had promising hypoglycemic effect via
inhibition of a- glucosidase with the lowest IC50 value of
Table 1 Total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity assays (DPPH, FRAP) and a-glucosidase
inhibitory activity of S. zalacca extracts.
Extracts (ethanol/water) TPC (mg GAE/g) TFC (mg QU/100 g) DPPH% FRAP (lg AAE/g) a-glucosidase (IC50 mg/mL)
0% (E0) 3.08 ± 0.22a 4.96 ± 0.24a 36.18 ± 0.18a 55.46 ± 2.50a 271.46 ± 15.55a
20% (E20) 5.66 ± 0.49b 8.11 ± 0.28b 39.22 ± 0.94b 63.43 ± 3.02b 156.12 ± 9.96b
40% (E40) 8.81 ± 0.69c 8.51 ± 0.52b 40.59 ± 0.72b 72.54 ± 1.94c 175.81 ± 12.41c
60% (E60) 14.94 ± 0.96d 11.45 ± 0.56a 54.14 ± 1.61c 78.13 ± 1.31c 15.94 ± 2.52de
80% (E80) 13.96 ± 1.66d 12.37 ± 0.50ad 61.32 ± 1.15d 78.39 ± 2.09c 26.82 ± 1.49d
100% (E100) 14.65 ± 0.56d 10.99 ± 0.23d 55.95 ± 0.73c 75.55 ± 2.51c 19.15 ± 1.82de
Ascorbic acid ND ND 99.04 ± 0.22e ND ND
Quercetin ND ND ND ND 4.89 ± 0.48e
Values represent the mean ± standard deviation (SD), n = 6.
The different small letter represents a significant difference (P < 0.05).
ND: not determined.
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to that of the positive control i.e. quercetin. The highest value
reflecting the lowest activity was observed for the E0 extract
with the IC50 value of 271.46 mg/mL. Besides, E80 and E100
also showed potential IC50 values. Overall, 60% ethanolic sol-
vent had potential to extract a- glucosidase inhibitors from S.
zalacca fruits extracts.
3.4. MS-based metabolites profiling
Multivariate data analysis was used to determine the correla-
tion between the bioactivity and the analysed spectra to iden-
tify the potential inhibitors that may be presented in the S.
zalacca fruits extracts. By using the discriminant analysis, the
OPLS model was carried out to show discrimination among
the extracts and to identify the signals with m/z values (mass
to charge ratio) together with their retention times that were
significantly correlated with a-glucosidase inhibition activity
(Javadi et al., 2014). The negative ionization was used, and
the data were explained with 2 principal components (OPLS
components 1 & 2). The identity of metabolites and IC50 val-
ues of the tested samples were considered as variables x and
y, respectively. The goodness of fit for this model was depen-
dent on the cumulative values in which Q2Y of the response
as predicted by the model. The cross validation and R2Y indi-
cates the validation of the model. In this study, Q2Y the R2Y
values were 0.825 and 0.963, respectively. Thus, the model was
considered good and free from overfitting since the cumulative
values for both R2Y and Q2Y were greater than 0.5 (Eriksson
et al., 2006). RMSEE was used to measure the performance
and accuracy of the model by calculating the model’s average
deviation from the data. Also, RMSECV was used in measur-
ing performance and accuracy by determining the quality of
the model to predict new samples. Lower RMSECV value indi-
cates high predictive accuracy for the new samples. For this
model, the RMSEE and the RMSECV values were found to
be close to each other with values of 0.0194748 and
0.040409, respectively.
Fig. 1 indicates the score scatter plot of the various extrac-
tions were obtained from LC-MS negative mode of ionization.
The plot demonstrates the distribution of the variables
obtained from OPLS components 1 and 2 (13% and 10.2%).
It vividly showed that there was a clear separation between
the active and less active extracts from S. zalacca. Based onOPLS component 1, the active extracts (E100, E80 and E60)
were well spread across the negative quadrant far from the
other extracts, which were located in the positive quadrant.
Fig. 2 represents the loading scatter plot of the different
extracts of the S. zalacca fruit based on the negative ionization
mode of the LC-MS. The samples with lowest IC50 values had
the highest activity. Thus, the metabolites measured to be pos-
itively correlated with the a-glucosidase inhibiting activity
were those labelled far from the IC50 value. The contribution
of metabolites to a-glucosidase inhibitory activity from this





1-carboxamide, (SZ4) Ethyl 4-[5-methyl-2-oxo-10,20,50,60,70,70a-
hexahydro-1H-spiro[indole-3,30-pyrrolizine]-20-ylamido]benzo
ate. Moreover, these compounds were abundant in the active
extracts and they were considered as chemical markers. For
model validation, the observed versus predicted plot, and the
regression equation were used to check the OPLS model.
The R2 value obtained was 0.9243. The model is valid and
R2 was great with value of 0.9717 (Fig. 3).
3.5. Structure elucidation of bioactive compounds using
fragmentation pathway
Elucidation of chemical structure of each parent ion was
achieved by using MS-MS fragmentations. Confirmation of
the metabolite identified was achieved through direct compar-
ison with the databases, such as ACD Lab, Inc. (Toronto,
Canada), previously published reports and the fragmentation
pattern of the ions. Table 2 shows the summary of the





1-carboxamide, (SZ4) Ethyl 4-[5-methyl-2-oxo-10,20,50,60,70,70a-
hexahydro-1H-spiro[indole-3,30-pyrrolizine]-20-ylamido]benzo
ate (Fig. 4).
Compound (SZ1) carexane I is a tricyclic compound bear-
ing two methoxy groups on the ring A and 2-propenyl group
on the saturated ring. In carexane I, the negative ionization
Fig. 1 The orthogonal partial least-squares (OPLS) plots (PC1 vs. PC2) of the discrimination of S. zalacca extracts with various ethanol
ratios (E0, E20, E40, E60, E80. E100) The numbers refer to the ethanol/water ratio; 0% (E0); 20% (E20); 40% (E40); 60%; (E60) 80%
(E80) and 100% (E100).





carboxamide; SZ4, Ethyl 4-[5-methyl-2-oxo-10,20,50,60,70,70a-
hexahydro-1H-spiro[indole-3,30-pyrrolizine]-20-ylamido] benzoate.
Fig. 3 The regression plot of OPLS of S. zalacca extracts with
various ethanol ratios (E0, E20, E40, E60, E80. E100) The
numbers refer to the ethanol/water ratio; 0% (E0); 20% (E20);
40% (E40); 60%; (E60) 80% (E80) and 100% (E100).
6 M.S.M. Saleh et al.mode (ESI) revealed that it was protonated at the methoxy
group, with an m/z of 323. The removal of acetaldehyde
(C2H4O) from this ion resulted in the formation of ions with
m/z of 279. The loss of C2H4O2 from the parent ion resulted
in the formation of the ion with an m/z of 263. In another
pathway, the parent ion lost C6H8O2 to form the fragment
with an m/z of 211. The removal of C8H6O from this parent
ion resulted in the formation of ions with m/z of 205. A furtherfragmentation of the parent ion with a loss of C10H10O2
resulted with an m/z of 161 subsequently loss of C10H12O3
from the parent ion formed the ion with an m/z of 143. Finally,
loss of C13H16O from parent ion resulted into a fragment with
m/z of 135.
Compound (SZ2) is a substituted derivative of hexahydro
furofuran with a substitution of 5-phenoxy-1,2,3,4-tetrazol-1-
yl and 3-ethylurea groups. The negative ionization mode
Fig. 4 Chemical structures of bioactive compounds identified




ene-1-carboxamide; SZ4, Ethyl 4-[5-methyl-2-oxo-10,20,50,60,70,
70a-hexahydro-1H-spiro[indole-3,30-pyrrolizine]-20-ylamido] benzoate.
Metabolomics-based profiling with chemometric approach to identify bioactive compounds 7(ESI) formed the parent ion [MH-] with an m/z of 359.
Removal of ethyl amine (C2H6N) fragment from the parent
































20-ylamido] benzoate(-C6H4) from the parent ion yielded an ion at m/z 283 which
on further fragmentation by losing an ethyl (C2H4) group pro-
duced an ion with an m/z of 255 which on rearrangement
cyclized with furan ring with an m/z of 255. The subsequent
loss of ethyl urea (C3H8N2O) and phenyl ring (C6H4) from
parent ion peak resulted into a fragment with m/z of 197. Loss
of ethyl urea (C3H8N2O) from the parent ion resulted into a
fragment at m/z 271 which was further fragmented with a loss
of phenoxy ring (C6H4O) and yielded a fragment with m/z of
179. Deprotonation of parent ion at furan ring resulted into
an open the ring which was further rearranged to three mem-
bered ring with a loss of (C10H8N4O2) resulted into a fragment
with m/z 143. Rearrangement of parent ion and loss of
(C11H10N4O3) resulted into fragment with a four membered
ring with m/z of 113 which further rearranged with m/z of
113. Deprotonation of parent ion and with several rearrange-
ment resulted into a fragment with m/z of 101 which on further
loss of (C12H10N5O2) yielded into a fragment with m/z of 89.
Lastly, loss of (C15H18N2O) resulted into a hydroxy-
tetrazolyl moiety with m/z of 85 which further rearranged to
four membered cyclic ring with m/z of 71.
Compound (SZ3) was tentatively identified as (3-acetylphe
noxy)-4,5-dihydroxycyclohexenyl-formamido-4-methylpenta
namide, during negative ionization mode (ESI) formed the
parent ion [MH-] with an m/z of 403. Loss of ammonia
(NH3) from the parent ion resulted into a fragment with m/z
of 386 and subsequently loss of propane moiety (C3H7) yielded
a fragment with m/z of 343. Deprotonation of parent ion on
amine and subsequently loss of water (H2O) resulted into a
fragment with m/z of 385 which on further loss of (C3H8)
yielded a moiety with m/z of 341. Removal of acetyl-ct based on the MS/MS fragmentation using negative ionization.
fragments ions Tentative metabolites
H4O]at m/z 279, [MC2H4O2]at
, [MC6H8O2]at m/z 211,
H6O]at m/z 205, [C10H10O2]at m/z



















N]at m/z 386, [MC3H7]at m/z
- H2O]at m/z 385, [MC3H6]at m/
MC8H8O2]at m/z 276, [MC3H8]
223, [MC9H14N2O2]at m/z 221,







at m/z 431, [MC7H6]at m/z 342

















8.24 LYS156, ASN415, GLU411, THR310, LEU313, PRO312 ARG315, PHE314
SZ1 7.59 THR274, SER298, ILE272 VAL266, ILE262, ARG263
SZ2 8.45 SER240, GLN239, SER241, LYS156, ASP242, GLN279, ASN415 TYR158, HIE280 ARG315
SZ3 7.69 GLY309 PRO312, ASP307, VAL308, ALA329
SZ4 9.67 HIE280, ARG315, ARG442 LYS156, ASP242, PHE159, PHE178,
GLU411
8 M.S.M. Saleh et al.phenoxy group (C8H8O2) from parent ion resulted into a frag-
ment with m/z of 267 which on further loss of (C3H8) yielded
into a fragment with m/z of 223. Removal of C9H14N2O2 from
parent ion resulted into a fragment with m/z of 221 and subse-
quently loss of oxygen yielded a fragment with m/z of 205. In
the last loss of methylene CH2 from the parent ion resulted
into a fragment with m/z of 389, several rearrangement and
loss of C12H20N2O4 moiety yielded a fragment with m/z of 133.
Compound (SZ4) Ethyl 4--5-methyl-2-oxo-10,20,50,60,70-hex
ahydro-1H-spiro[indole-3,30-pyrrolizine]-20-ylamido] benzoate,
during negative ionization mode the Protonation at propionate
group resulted in a parent ion with m/z of 432 [MH-] with a
loss of propionate group (C3H5O2) yielded a fragment with m/
z of 359 subsequently rearrangement of fragment and loss of
methane CH4 formed the fragment with m/z of 343. Removal
of benzyl (C7H6) radical from parent ion resulted a fragmentFig. 5 The 2D diagram of the interaction between the protein residu
arginine; ASP, aspartate; LYS, lysine; ASN, asparagine; GLU, gl
phenylalanine; CYS, cysteine; PRO, proline, TYR, tyrosine; VAL, vawith m/z of 342. Parent ion was further deprotonated at methyl
position in a negative ion mode with m/z of 431 while loss of
benzyl (C6H7) resulted a fragment at m/z of 341 subsequently
loss of (C18H21N3O4) resulted in a fragment with m/z of 89.
3.6. Docking of metabolites identified through MS/MS
All the identified metabolites responsible for the a-glucosidase
inhibition were docked to the Saccharomyces cerevisiae isoma-
ltase (SCI) crystal structure (PDB ID: 3A4A). The conforma-
tions showing the lowest binding energy for the compounds
along with the interacting residues are summarized in Table 3.
The binding energy of the compounds with the interacting
residues are shown in Table 3. Conducted docking simulation
was validated by the control ligand. Meanwhile, quercetin used
as positive control was analyzed in comparison to the com-es and the compounds A-SZ1, B-SZ2, C-SZ3 and D- SZ4. ARG,
utamate; THR, threonine; LEU, leucine; PRO, proline; PHE,
line; ILE, isoleucine; ALA, alanine, GLN, glutamine.
Metabolomics-based profiling with chemometric approach to identify bioactive compounds 9pounds. Two of the identified compounds demonstrated a
potentially lower binding energy from the docking results
when compared to quercetin used as positive control, while
the measured energy level for SZ2 and SZ4 were comparable
to the control ligand. This shows the binding affinity of the
metabolites to the protein chains compound SZ1 was observed
to interact with THR274, SER298 and ILE272 through both
H-bonding and Van der Waals interactions through
hydrophobic contact with VAL266, ILE262 and ARG263 with
a binding energy of 7.59 kcal/mol. Compound SZ2 displayed
a binding affinity of 8.45 kcal/mol for the H- bonding inter-
action with SER240, GLN239, SER241, LYS156, ASP242 and
GLN279, ASN415. The hydrophobic van der Waals interac-
tions was noticed with TYR158, HIE280 and ARG315. Com-
pound SZ3 also displayed a higher binding energy of
7.69 kcal/mol, involving interaction of GLY309 with the
nitrogen attached to the tetrazine cycle through H-bonding:
PRO312, ASP307, VAL308 and ALA329 residues through
hydrophobic contact. Compound SZ 3 showed lower binding
energy than the positive control despite only one residue inter-
action by a H-bond to its hydroxyl group.
Moreover, compound SZ4 showed a binding energy of
9.67 kcal/mol in which HIE280, ARG315 and ARG442
had interaction with a hydroxyl group through H-bonding;
LYS156, ASP242, PHE159, PHE178 and GLU411 residues
interacted via hydrophobic contact. All the above-mentioned
four compounds predominantly displayed a hydrophobic nat-
ure through interacting with protein hydrophobic residues
(Fig. 5). Fig. 6 illustrates the superimposed 3D diagram, repre-
senting the virtual binding site of the molecules in the enzy-
matic protein which exists predominantly in domain A which
has the catalytic region. It is important to note that the main
residues residing at the entrance of the active site pocket was
involved in the hydrophobic interaction of all compounds.
Overall, the interaction encompasses H-bonding with
hydrophobic interactions (Van der Waals and p interactions)
related to the nature of the compounds and interacting resi-
dues with the atoms. It was also observed that the binding site
for SZ2, SZ3 and SZ4 were close to the active site pocket
(Fig. 6), while SZ1 was outside of the pocket, indicating theFig. 6 Superimposition of the identified compounds, quercetin
and ADG in the binding site of enzyme.presence of allosteric binding sites that may possibly alter
the enzyme activity (Fig. 7).
4. Discussion
The inhibitors of a-glucosidase help in slowing down the liber-
ation of glucose from the disaccharides and oligosaccharides of
carbohydrates to delay the absorption of glucose and reduce
the postprandial glycemia in order to control hyperglycemia.
Metabolomics is a qualitative and quantitative analysis of all
metabolites present in an organism when subjected to different
factors (Abdul Hamid et al., 2017; Mediani et al., 2015, 2012).
Many advanced analytical tools are used in metabolomics to
obtain high throughput analysis of both targeted and untar-
geted metabolites. The LC-MS is an efficient and suitable tech-
nique for rapid identification of the different metabolites and
the abundance of primary metabolites. In recent times, LC-
MS combined with MVDA had been employed for profiling
and characterization of various plants (Javadi et al., 2015,
2014; Lawal et al., 2015; Mediani et al., 2012).
Compound (SZ1) Carexanes I is a new compound isolated
for the first time from Carex distachya Desf. It contains a rare
tricyclic skeleton which arises from a cyclization of prenyl stil-
benoid precursors. It has been reported to exhibit strong
antioxidant activity similar to ascorbic acid (Buommino
et al., 2017). Moreover, Buommino et al. (2017) (Lawal
et al., 2015) reported that carexanes could possibly be a candi-
date molecule for combatting the harmful effect of HspB pro-
tein and reduces the inflammatory process induced byH. pylori
infection. Compounds SZ1-3 belong to the alkaloid, secondary
metabolites in the fruits of S. zalacca. Alkaloids are nitrogen-
containing molecules mostly derived from amino acids. Many
alkaloids produced by plants are of high pharmaceutical value
and have been used for the treatment of various diseases
including diabetes (Choudhary et al., 2011; Zhen et al.,
2017). However, no scientific study has ever been carried out
for their a-glucosidase inhibition potential. In this regard,
molecular docking approach could help to discover their true
pharmacological potentials. Molecular docking is used for
rapid screening of large number of compounds. Docking
involves computation of ligand–protein interactions for molec-
ular recognition and also for fast screening of databases for
accurate prediction of the formation of protein structures
and protein–ligand complexes for principal structure-based
drug design (SBDD) (Lestari et al., 2017).
S. cerevisiae isomaltase structure consist of 589 amino acids
which are folded into three domains: A, B and C. Jointly, in
domain A the residues from 1 to 113 and 190–512 are found.
While those from 114 to 189 and 513–589 are included in
domain B and domain C, respectively. Domain A is regarded
as catalytic domain comprising the catalytic residues such as
ASP215, GLU277, and ASP352 located at the C-terminal.
Apart from the catalytic residues, ASP62, TYR72, and
ARG442 are also situated close to the active site. Therefore,
they are involved in the catalytic reaction. All residues having
interaction with ADG contribute to the catalytic reaction and
its binding energy. As indicated in Table 3, ADG showed
interaction with ASH215 (protonated ASP215), a
conserved residue acting as the catalytic nucleophile. ADG
also formed H-bond with the GLH277 (also protonated
GLU277) residue acting as the general acid-base catalytic
Fig. 7 Predicted binding mode of SZ2, SZ3, SZ4 and SZ1 with a-glucosidase on molecular surface.
10 M.S.M. Saleh et al.residue. Furthermore, ADG displayed interaction with
ASP352, responsible for the stabilization of the substrate dur-
ing the catalytic reaction, so to reinforce the acid-base hydrol-
ysis reaction (Lawal et al., 2015). Virtually, isomaltase active
site was occupied by five water molecules (which will bind to
some of the residues to aid the catalytic action) influencing
the enzyme’s activity. Precisely, the arrangement of the water
molecules will be in such a way that the chain is close to the
bottom of the active site pocket to form H-bonds directly with
ASP69, ARG446, and ASP409. These water molecules also
form H-bond with the N atom in VAL410 and GLU408 and
carbonyl oxygen atom in the GLU408 residue. Formation of
H-bond by water molecules also involves the GLU277,
ARG213, and ASP352 residues. The binding site surroundings
of water also has some hydrophobic amino acids such as,
PHE303, TYR387, TRP58, TYR347, PHE301, and TYR389.
The presence of these hydrophobic residues is due to the envi-
ronment’s hydrophobicity surrounding certain molecules of
water that could increase their mobility. The actual role of
these water molecules is to serve as a reservoir for the subse-
quent catalytic reaction to provide water and to work as a
water drain at the active site to boost the analog binding of
the substrate. Thus, despite the catalytic residues, the enzy-
matic activity also includes many other residues which interact
with inhibitors thereby causing non-competitive inhibition. It
is in fact obvious that the entrance of the active site pocket
of isomaltase is shallow and primarily restricted by HIS280,
TYR158, and loop 310–31 (Yamamoto et al., 2010).
From the docking results, it is was observed that SZ3 and
SZ4 were likely to interact via hydrophobic contacts with the
enzymatic protein residues therefore showing their hydropho-
bicity. Nevertheless, SZ3 and SZ4 showed better binding affin-
ity with the residues involved, which indicates their positive
potential toward the observed bioactivity. These compounds
also displayed comparably binding energy level than quercetin
used as positive control. The overall interactions involved pre-
dominantly, the residues residing in both domains A and B.
Compound SZ1 interactions typically involved residues at
domain A but not with the catalytic residues. This may suggest
that there was an indirect involvement of the compoundscausing the inhibition of the enzymatic activity and also a
non-competitive inhibition mode through an allosteric site
interaction. All the remaining compounds displayed at least
one interaction with the residues residing at the entrance of
the active site pocket in which ASP242 was observed to show
interaction with compounds 2 and 4, and ASP307 with com-
pound 4. Zheng et al. (2017) reported that increasing the num-
ber of aromatic rings and addition of hydrogen-bond acceptor
substituents at the 3-position were identified to be important to
enhance the bioactivities of xanthones. Furthermore, these
compounds also interact with residues in domain A through
hydrophobic interaction close to the active site region suggest-
ing that the compounds were acting in a non-competitive inhi-
bition manner which result in an inhibitory action.
For this study, the in-silico docking simulation had con-
vincingly provided supportive information on the possible
interaction between identified inhibitors and the enzyme and
hence enabling the prediction of the mode of inhibition and
activity of the compounds. However, the enzyme-inhibitor
complex can also be easily visualized using this technique
and more investigations are required to evaluate the bioactivity
of the identified compounds. This may be of advantage to
determine their potential strength in the observed bioactivity
and confirm their actual mechanism of actions. All the com-
pounds identified were likely to interact with the residues of
enzymatic protein through hydrophobic and H-bond contact.
However, SZ1 showed an outstanding binding affinity with
the bound residues. This demonstrated their potential toward
the observed bioactivity.
5. Conclusion
The present study reports, for the first time, a detailed investi-
gation on the flesh of S. zalacca fruits involving LC-QTOF-
MS-based metabolomics. Findings presented herein revealed
that S. zalacca extracts resulted from various ratio of ethanol
and water demonstrated different effects in scavenging DPPH
radicals, ferric reducing antioxidant power and inhibiting the
a-glucosidase enzyme. The E60 extract showed potent
a-glucosidase inhibition and antioxidant (FRAP)with IC50
Metabolomics-based profiling with chemometric approach to identify bioactive compounds 11values of 15.94 mg/mL and 78.13 lg AAE/g respectively. The
constituents in the active extract were characterized using
MS/MS method. A total 4 compounds reported for the first
time in this fruit were identified carexane I, 5-phenoxytetra
zol-1-yl)-2,3,5,6-hexahydrofurofuran-3-ethylurea, 3-acetylphe
noxy)-N-[(2)-1-amino-4-methyl-1-oxopentan-2-yl]-4,5-dihy
droxycyclohexene-1-carboxamide and Ethyl 4-[5-methyl-2-ox
o-10,20,50,60,70,70a-hexahydro-1H-spiro[indole-3,30-pyrrolizine]-
20-ylamido] benzoate. The molecular interactions of the inhibi-
tors identified with the protein were predominantly hydrogen
bonding involving residues namely THR274, SER298,
ILE272, SER240, GLN239, SER241, LYS156, ASP242,
GLN279, ASN415, HIE280, ARG315, ARG442, and
GLY309 residues with hydrophobic interaction. In conclusion,
this study provides evidence that S. zalacca fruits possesses
antioxidant and a-glucosidase inhibition activities and may
be an asset to the development of food industry and medicinal
preparation.
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